Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | 750,000 | reported | 25 Mar 2026 | tx 32+2,755,353−992,553 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Mar 2026 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 750,000 | 0.00 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 267,500 | 0.00 USD | deriv |
| 10 Jul 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 11,653 | 14.42 USD | |
| 10 Jul 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,270 | 15.78 USD | |
| 10 Jul 2024 | SALE | 4D Molecular Therapeutics, Inc. | 12,923 | 22.49 USD | |
| 10 Jul 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,270 | 0.00 USD | deriv |
| 10 Jul 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 11,653 | 0.00 USD | deriv |
| 24 Jun 2024 | SALE | 4D Molecular Therapeutics, Inc. | 12,930 | 23.10 USD | |
| 24 Jun 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 12,930 | 14.42 USD | |
| 24 Jun 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 12,930 | 0.00 USD | deriv |
| 08 Feb 2024 | SALE | 4D Molecular Therapeutics, Inc. | 92,001 | 27.13 USD | |
| 23 Jan 2024 | SALE | 4D Molecular Therapeutics, Inc. | 5,696 | 18.41 USD | |
| 15 Dec 2023 | SALE | 4D Molecular Therapeutics, Inc. | 28,632 | 17.27 USD | |
| 05 Jan 2024 | SALE | 4D Molecular Therapeutics, Inc. | 133 | 20.11 USD | anomaly |
| 18 Dec 2023 | SALE | 4D Molecular Therapeutics, Inc. | 4,702 | 18.13 USD | |
| 05 Jan 2024 | SALE | 4D Molecular Therapeutics, Inc. | 28,104 | 19.56 USD | |
| 04 Jan 2024 | SALE | 4D Molecular Therapeutics, Inc. | 40,732 | 20.31 USD | |
| 11 Dec 2023 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 590,000 | 0.00 USD | deriv |
| 02 May 2023 | GIFT | 4D Molecular Therapeutics, Inc. | 600,000 | 0.00 USD | |
| 02 May 2023 | GIFT | 4D Molecular Therapeutics, Inc. | 600,000 | 0.00 USD | |
| 21 Feb 2023 | SALE | 4D Molecular Therapeutics, Inc. | 17,090 | 20.93 USD | |
| 22 Feb 2023 | SALE | 4D Molecular Therapeutics, Inc. | 16,449 | 20.22 USD | |
| 21 Feb 2023 | SALE | 4D Molecular Therapeutics, Inc. | 907 | 21.49 USD | |
| 10 Feb 2023 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 222,000 | 0.00 USD | deriv |
| 20 Jan 2023 | SALE | 4D Molecular Therapeutics, Inc. | 8,625 | 20.19 USD |